Home Diagnostic Imaging International Corp.

May 16, 2013
AMI Research Initiates Coverage on Diagnostic Imaging International Corp. with a Speculative Buy Rating of $0.62

Las Vegas, May 16, 2013 -- AMI Research, a leading provider of equity research reports and a subsidiary of Hawk Associates Inc., announced today that it has initiated equity research coverage on Diagnostic Imaging International Corp. (OTCQB:DIIG) with a Speculative Buy rating of $0.62 per share.

AMI president Peter J. D'Agostino said, "We think DIIG is poised for substantial growth with the completion of its first, stand-alone MRI diagnostic facility. Operating MRI facilities offers significant sources of revenue for healthcare providers as the facilities are generally supported by favorable reimbursement rates from insurers and government programs. We contend that DIIG's diagnostic business unit will be the catalyst for the company's significant revenue expansion. In addition, we cannot ignore DIIG's teleradiology business, which yields positive cash-flow."

AMI Research provides an institutional-quality, equity research initiation report detailing DIIG's key statistics, management, growth catalysts, financial outlook, price target, and valuation. The complete eight-page report is available to download for free at the AMI Research website, http://www.amistockreports.com/DIIG_Initiation.pdf

About AMI Research
AMI Research provides equity research coverage for promising companies that do not have traditional Wall Street analyst coverage. Coverage by AMI ensures an objective explanation of all facets of a business and increased exposure to numerous institutional and retail investors seeking reputable investment ideas. AMI combines in-depth, insightful research and customized graphics into detailed analyst reports to create an investment thesis with a four tier rating system and 12-month price target. These reports detail the company's industry, strategic position, core business model, financial history, future growth catalysts and projected financials. Please visit http://www.amistockreports.com. For more information, contact Peter J. D'Agostino, president at 212.541.2465, email to: p.dagostino@amistockreports.com.

AMI Research

Peter J. D'Agostino, 212-541-2465

About Diagnostic Imaging International Corp.
Diagnostic Imaging International Corp., ("DIIG") owns and operates CTS a Teleradiology company, and SMI an MRI clinic. Teleradiology is the process of assessing radiological patient images, such as x-rays, CTs, and MRIs, from one location to another for the purposes of interpretation and/or consultation. CTS provides remote radiology (teleradiology) technology to hospitals and practices, on-call 24 hours a day, 7days a week. CTS connects clients with a global teleradiology network, providing access to global partner facilities and American and Canadian board-certified radiologists. SMI provides full out-patient MRI diagnostic scans and results, and offers its patients both an open MRI and closed 1.5T MRI depending on needs and requirements.

To find out more about Diagnostic Imaging International Corp. (OTCQB: DIIG), visit our website at diig.biz. Or contact the Company directly at (877) 331-3444.

Product software development with Glorium Technologies 

This web site includes forward-looking statements that reflect Diagnostic Imaging International Corp. and its subsidiary companies' current expectations about its future results, performance, prospects and opportunities. Diagnostic Imaging International Corp. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to Diagnostic Imaging International Corp. and are subject to a number of risks, uncertainties and other factors that could cause Diagnostic Imaging International Corp.'s actual results, performance, prospects or opportunities in the remainder of and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.